Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Prednisolone Acetate 1% Ophthalmic Suspension Manufacturer

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Nac Pharmaceuticals is seeking a subcontractor to manufacture and supply Prednisolone Acetate 1% Ophthalmic Suspension for Department of Veterans Affairs pharmaceutical supply contracts. The selected provider will be responsible for the formulation, production, filling, and sealing of both 5 ML and 10 ML bottles within sterile manufacturing facilities. To qualify, the manufacturer must maintain FDA registration, ensure full cGMP compliance, and possess a unique NDC number. The annual delivery requirements consist of 392,107 bottles of the 5 ML size and 70,070 bottles of the 10 ML size. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 15, 2026.

General Info

Nac Pharmaceuticals seeks FDA-registered subcontractors to manufacture Prednisolone Acetate ophthalmic suspensions.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79726R0037.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Prednisolone 1% Ophthalmic Solution

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufactures and supplies Prednisolone Acetate 1% Ophthalmic Suspension for prime contractors on Department of Veterans Affairs (VA) pharmaceutical supply contracts. Performs formulation, production, filling, and sealing of 5 ML and 10 ML bottles in sterile manufacturing facilities. Requires FDA registration, cGMP compliance, and a unique NDC number. Delivers 392,107 5 ML bottles and 70,070 10 ML bottles annually.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Prednisolone 1% Ophthalmic Solution
Solicitation # 36E79726R0037
The Department of Veterans Affairs Enterprise Procurement Office is initiating an unrestricted procurement under solicitation 36E79726R0037 for Prednisolone Acetate 1% Ophthalmic Suspension. This contract aims to establish an uninterrupted source of supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a base period of one year, with four subsequent pre-priced one-year option periods. Estimated annual requirements include 392,107 bottles of the 5ml size, 70,070 bottles of the 10ml size, and 10,172 bottles of the 15ml size. The procurement is conducted in commercial item format per FAR Part 12 under NAICS code 325412. Strict labeling and packaging standards are required: offerors must provide a unique NDC number, and the contractor's label must be the only label on the product, with no over-labeling permitted. Bottles must accommodate a label measuring 5.25 by 2 inches, including an additional 0.5 inch of space to keep barcodes, lot numbers, and expiration dates exposed, while ensuring VA labels can securely adhere on top. The RFP is expected to be issued around October 1, 2026, with a tentative closing date of October 15, 2026. All submissions and updates will be handled electronically via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

about 23 hours ago

DEADLINE

in 19 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS